Blauvelt, A. ., Wollenberg, A., Pink, A., Peris, K. ., Armstrong , A., Spelman, L., Saeki, H., Lynde, C., Herranz, P., Barbarot, S., & Simpson, E. (2021). Assessing long-term maintenance of efficacy with tralokinumab monotherapy in patients with moderate-to-severe atopic dermatitis: combined results from two phase 3, randomized, double-blind, placebo-controlled trials (ECZTRA 1 and 2). SKIN The Journal of Cutaneous Medicine, 5(6), s57.